Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study
- 15 July 1993
- Vol. 72 (2) , 511-518
- https://doi.org/10.1002/1097-0142(19930715)72:2<511::aid-cncr2820720230>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Application of Automated Immunochemistry for Assessing Estrogen and Progesterone Receptors in Patients with Breast CancerJournal of Histotechnology, 1989
- Stage IB adenocarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissectionAmerican Journal of Obstetrics and Gynecology, 1989
- Histological grade and steroid receptor content of primary breast cancer – impact on prognosis and possible modes of actionBritish Journal of Cancer, 1988
- Squamous and adenocarcinoma of the uterine cervix: a comparison using routine dataBritish Journal of Cancer, 1987
- The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breastBritish Journal of Cancer, 1985
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- The effect of estrogen receptor status on survival in patients with endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1983
- Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: Clinical and histopathologic correlatesAmerican Journal of Obstetrics and Gynecology, 1983
- Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implicationsAmerican Journal of Obstetrics and Gynecology, 1981
- Systemic chemotherapy for carcinoma of the cervixAmerican Journal of Obstetrics and Gynecology, 1967